All Posts Tagged With: "GERN"
(GERN) Geron 2011 First Quarter Posts Wider Loss
Geron Corporation (GERN) posted a net loss of 20 cents per share in the first quarter of 2011, wider than the Zacks Consensus Estimate of a loss of 19 cents and the year-ago loss of 18 cents. First quarter...
(GERN) Geron’s Earnings Report Misses Expectations
Geron Corporation (GERN) posted a net loss of $18.4 million, or 20 cents per share in the fourth quarter of 2009, higher than the Zacks Consensus Estimate of a loss of 17 cents. However, the result was better...
(GERN) Geron’s GRNVAC1 Vaccine Shows Promise
Biotech company Geron (GERN) recently presented encouraging interim data on its pipeline candidate, GRNVAC1, at the annual meeting of the American Society of Hematology (ASH). GRNVAC1 is a vaccine, which...
(GERN) Geron FDA Experimental Application on Hold
Yesterday, Geron Corp. (GERN) provided an update on its experimental candidate, GRNOPC1, which is currently under clinical hold. On Aug. 18, Geron suffered a setback when the US Food and Drug Administration (FDA) put its Investigational New Drug (IND) application...
(GERN) Geron Corporation: Stock of the Day
by Katharine Schildt, Assistant Editor, The Oxford Club
A New Era for Stem Cell Research
Stem cell research has been a controversial subject for quite some time. And it’s been no secret that the Bush administration wasn’t a big fan....